In terms of market performance, Ultragenyx Pharmaceutical Inc. had a somewhat regular. The highest value for the stock in the past year was $54.98 on 06/06/23, while the lowest value was $31.52 on 10/24/23.
52-week price history of RARE Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Ultragenyx Pharmaceutical Inc.’s current trading price is -19.77% away from its 52-week high, while its distance from the 52-week low is 39.94%. The stock’s price range for this period has remained between $31.52 and $54.98. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.89 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.74 million over the last three months.
Financial Performance and Market Capitalization
Ultragenyx Pharmaceutical Inc. (RARE) has experienced a quarterly rise of 1.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.63B and boasts a workforce of 1276 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 46.19, with a change in price of +5.27. Similarly, Ultragenyx Pharmaceutical Inc. recorded 767,676 in trading volume during the last 100 days, posting a change of +13.57%.
RARE Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RARE stands at 3.39. Similarly, the long-term debt-to-equity ratio is also 3.24.
RARE Stock Stochastic Average
As of today, the raw stochastic average of Ultragenyx Pharmaceutical Inc. over the last 50 days is at 16.73%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 19.91%. Further, the company’s Stochastic %K and %D values for the last 20 days were 10.30% and 19.79%, respectively.
RARE Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -7.76%. However, over the past six months, we’ve seen a weaker performance of 19.15%. The price of RARE leaped by -5.32% over the last 30 days. And in the last five days, it has fallen by -14.53%.
